FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562396666> ?p ?o ?g. }

• W2562396666 endingPage "35" @default.
• W2562396666 startingPage "35" @default.
• W2562396666 abstract "Interleukin-34 (IL-34) was initially identified as an alternative ligand for the colony-stimulating factor-1 receptor (CSF-1R) to mediate the biology of mononuclear phagocytic cells. Recently, IL-34 was found to be associated with chronic inflammation, such as in rheumatoid arthritis (RA). Both RA and systemic lupus erythematosus (SLE) are multifactorial autoimmune diseases and are characterized by excessive immune and inflammatory responses. Thus, we investigated whether IL-34 is involved in the pathogenesis of SLE. In all, 78 SLE patients and 53 healthy controls were enrolled in the research. Enzyme-linked immunosorbent assay (ELISA) was employed to measure the concentrations of serological IL-34. Then serum IL-34 levels between the SLE group and healthy controls were analyzed by the Mann-Whitney U test. Meanwhile, the correlations between the serum IL-34 levels and disease activity indexes and other established serum markers were assessed. Furthermore, the serum IL-34 levels of 20 active SLE patients were reevaluated when diseases were in the remission stage from corticosteroids or immunosuppressive drugs. Serum IL-34 levels were significantly higher in SLE patients compared to healthy controls. Their levels were remarkably associated with accumulation of the clinical features of SLE. Additionally, IL-34 titers were positively correlated with the SLE disease activity indexes, anti-double-stranded DNA antibody (anti-dsDNA) titers and C-reactive protein (CRP) levels, and inversely with complement3 (C3) levels. Moreover, serum IL-34 levels were significantly decreased after successful treatment of SLE. Serum IL-34 could be a candidate biomarker for SLE as there are elevated serum levels in treatment-naive SLE patients and we saw a significant decrease after effective treatment." @default.
• W2562396666 created "2017-01-06" @default.
• W2562396666 creator A5020732505 @default.
• W2562396666 creator A5048300326 @default.
• W2562396666 creator A5066375612 @default.
• W2562396666 date "2016-12-28" @default.
• W2562396666 modified "2023-09-25" @default.
• W2562396666 title "Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus" @default.
• W2562396666 cites W1971859451 @default.
• W2562396666 cites W1991636716 @default.
• W2562396666 cites W1994581225 @default.
• W2562396666 cites W2000308852 @default.
• W2562396666 cites W2003863305 @default.
• W2562396666 cites W2015314347 @default.
• W2562396666 cites W2050386938 @default.
• W2562396666 cites W2054080837 @default.
• W2562396666 cites W2056273927 @default.
• W2562396666 cites W2061462004 @default.
• W2562396666 cites W2064999867 @default.
• W2562396666 cites W2065036402 @default.
• W2562396666 cites W2070484917 @default.
• W2562396666 cites W2070527591 @default.
• W2562396666 cites W2076093906 @default.
• W2562396666 cites W2078895122 @default.
• W2562396666 cites W2096250597 @default.
• W2562396666 cites W2122801249 @default.
• W2562396666 cites W2155952957 @default.
• W2562396666 cites W2167446675 @default.
• W2562396666 cites W2177646845 @default.
• W2562396666 cites W2513312047 @default.
• W2562396666 doi "https://doi.org/10.3390/molecules22010035" @default.
• W2562396666 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6155597" @default.
• W2562396666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28036035" @default.
• W2562396666 hasPublicationYear "2016" @default.
• W2562396666 type Work @default.
• W2562396666 sameAs 2562396666 @default.
• W2562396666 citedByCount "33" @default.
• W2562396666 countsByYear W25623966662016 @default.
• W2562396666 countsByYear W25623966662017 @default.
• W2562396666 countsByYear W25623966662018 @default.
• W2562396666 countsByYear W25623966662019 @default.
• W2562396666 countsByYear W25623966662020 @default.
• W2562396666 countsByYear W25623966662021 @default.
• W2562396666 countsByYear W25623966662022 @default.
• W2562396666 countsByYear W25623966662023 @default.
• W2562396666 crossrefType "journal-article" @default.
• W2562396666 hasAuthorship W2562396666A5020732505 @default.
• W2562396666 hasAuthorship W2562396666A5048300326 @default.
• W2562396666 hasAuthorship W2562396666A5066375612 @default.
• W2562396666 hasBestOaLocation W25623966661 @default.
• W2562396666 hasConcept C126322002 @default.
• W2562396666 hasConcept C159654299 @default.
• W2562396666 hasConcept C203014093 @default.
• W2562396666 hasConcept C2775915377 @default.
• W2562396666 hasConcept C2776912625 @default.
• W2562396666 hasConcept C2776914184 @default.
• W2562396666 hasConcept C2777077863 @default.
• W2562396666 hasConcept C2777575956 @default.
• W2562396666 hasConcept C2778690821 @default.
• W2562396666 hasConcept C2779075594 @default.
• W2562396666 hasConcept C2779134260 @default.
• W2562396666 hasConcept C2780942790 @default.
• W2562396666 hasConcept C2781197716 @default.
• W2562396666 hasConcept C45189115 @default.
• W2562396666 hasConcept C55493867 @default.
• W2562396666 hasConcept C71924100 @default.
• W2562396666 hasConcept C74172505 @default.
• W2562396666 hasConcept C86803240 @default.
• W2562396666 hasConcept C8891405 @default.
• W2562396666 hasConceptScore W2562396666C126322002 @default.
• W2562396666 hasConceptScore W2562396666C159654299 @default.
• W2562396666 hasConceptScore W2562396666C203014093 @default.
• W2562396666 hasConceptScore W2562396666C2775915377 @default.
• W2562396666 hasConceptScore W2562396666C2776912625 @default.
• W2562396666 hasConceptScore W2562396666C2776914184 @default.
• W2562396666 hasConceptScore W2562396666C2777077863 @default.
• W2562396666 hasConceptScore W2562396666C2777575956 @default.
• W2562396666 hasConceptScore W2562396666C2778690821 @default.
• W2562396666 hasConceptScore W2562396666C2779075594 @default.
• W2562396666 hasConceptScore W2562396666C2779134260 @default.
• W2562396666 hasConceptScore W2562396666C2780942790 @default.
• W2562396666 hasConceptScore W2562396666C2781197716 @default.
• W2562396666 hasConceptScore W2562396666C45189115 @default.
• W2562396666 hasConceptScore W2562396666C55493867 @default.
• W2562396666 hasConceptScore W2562396666C71924100 @default.
• W2562396666 hasConceptScore W2562396666C74172505 @default.
• W2562396666 hasConceptScore W2562396666C86803240 @default.
• W2562396666 hasConceptScore W2562396666C8891405 @default.
• W2562396666 hasIssue "1" @default.
• W2562396666 hasLocation W25623966661 @default.
• W2562396666 hasLocation W25623966662 @default.
• W2562396666 hasLocation W25623966663 @default.
• W2562396666 hasLocation W25623966664 @default.
• W2562396666 hasOpenAccess W2562396666 @default.
• W2562396666 hasPrimaryLocation W25623966661 @default.
• W2562396666 hasRelatedWork W1503288527 @default.
• W2562396666 hasRelatedWork W1968509366 @default.
• W2562396666 hasRelatedWork W2076597215 @default.

• next